Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial

Roman Rouzier; Sébastien Gouy; Frédéric Selle; Eric Lambaudie; Anne Floquet; Virginie Fourchotte; Christophe Pomel; Pierre-Emmanuel Colombo; Elsa Kalbacher; Sandrine Martin-Francoise; Raffaèle Fauvet; Philippe Follana; Anne Lesoin; Fabrice Lecuru; Youssef Ghazi; Julien Dupin; Elisabeth Chéreau; Sarah Zohar; Paul Cottu; Florence Joly

doi:10.1016/j.ejca.2016.09.036

Back

Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial

Journal article

Open access

Peer reviewed

Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial

Roman Rouzier, Sébastien Gouy, Frédéric Selle, Eric Lambaudie, Anne Floquet, Virginie Fourchotte, Christophe Pomel, Pierre-Emmanuel Colombo, Elsa Kalbacher, Sandrine Martin-Francoise, …

European Journal of Cancer, Vol.70, pp.133 - 142

01/2017

DOI: https://doi.org/10.1016/j.ejca.2016.09.036

PMID: 27914243

Abstract

Bevacizumab

Interval debulking surgery

Neoadjuvant chemotherapy

To investigate whether adding bevacizumab to neoadjuvant carboplatin-paclitaxel (CP) helps achieve optimal debulking, measured by complete resection rate (CRR) at interval debulking surgery (IDS), in patients with initially unresectable International Federation of Gynecology and Obstetrics stage IIIC/IV ovarian, tubal or peritoneal adenocarcinoma.

Files and links (2)

url

Find in HALView

url

https://doi.org/10.1016/j.ejca.2016.09.036View

Published (Version of record) Open

Metrics

1 Record Views

See more details

Details

Title: Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial
Creators - without role: Roman Rouzier - Université de Versailles Saint-Quentin-en-Yvelines
Sébastien Gouy - Institut Gustave Roussy
Frédéric Selle - Sorbonne Université
Eric Lambaudie - Institut Paoli-Calmettes
Anne Floquet - Institut Bergonié
Virginie Fourchotte - Institut Curie
Christophe Pomel - Centre Jean Perrin
Pierre-Emmanuel Colombo - Université de Montpellier, Institut de Recherche en Cancérologie de Montpellier - IRCM
Elsa Kalbacher - Centre Hospitalier Universitaire de Besançon
Sandrine Martin-Francoise - Centre François Baclesse
Raffaèle Fauvet - Centre Hospitalier Universitaire Amiens-Picardie
Philippe Follana - Centre Antoine Lacassagne
Anne Lesoin - Centre Oscar Lambret
Fabrice Lecuru - Hôpital Européen Georges-Pompidou
Youssef Ghazi - Roche
Julien Dupin - Roche
Elisabeth Chéreau - Institut Paoli-Calmettes
Sarah Zohar - Centre de Recherche des Cordeliers
Paul Cottu - Institut Curie
Florence Joly - Centre François Baclesse
Publication Details: European Journal of Cancer, Vol.70, pp.133 - 142
Identifiers: 9945174909311
Academic Unit: Institut de Recherche en Cancérologie de Montpellier - IRCM
Language: English
Resource Type: Journal article
Local Fields: hal-01658616